Source: International Congress 2018 – Evolving approaches to differential diagnosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Schuermans (Brussels, Belgium), S. Verschraegen (Ghent, Belgium), G. Celis (Leuven, Belgium), E. Vanderhelst (Brussels, Belgium). Is a screening spirometry a good screening tool?. 309

Member's Comments

No comment yet.

Related content which might interest you: Is spirometry screening useful for detecting undiagnosed COPD? Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 Development and validation of a simple tool for the assessment of home noninvasive ventilation: the S3-NIV questionnaire Source: Eur Respir J, 52 (5) 1801182; 10.1183/13993003.011822018 Year: 2018 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Screening spirometry is too expensive and inaccurate for detecting COPD in the general public Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Free running asthma screening test (FRAST): a useful tool or a waste of time? Source: Eur Respir J 2001; 18: Suppl. 33, 495s Year: 2001 Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also? Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006 Non-invasive diagnostics: modern measures for screening and diagnosis Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 What are the benefits of medical screening and surveillance? Source: Eur Respir Rev 2013; 22: 96-97 Year: 2013 What are the benefits of medical screening and surveillance? Source: Eur Respir Rev 2013; 22: 96 Year: 2013 Evaluating a simple lung monitor as a screening test for COPD in primary care Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Development and validation of a simple tool for clinical assessment of patients treated with home NIV: The S3-NIV questionnaire Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017 Individualised field testing is a useful tool to evaluate difficult asthma. Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 Happy ever after? A new assessment tool for long-term noninvasive ventilation: the S3-NIV questionnaire Source: Eur Respir J, 52 (5) 1801969; 10.1183/13993003.01969-2018 Year: 2018 Developing screening questionnaires for COPD Source: Eur Respir J 2003; 22: Suppl. 45, 375s Year: 2003 Scar-in-a-Jar, an in vitro screening tool for antifibrotics Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Is FEV1/FEV6 ratio a reliable  tool in COPD diagnosis ? Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Interpretating the results of spirometry and anamnesis into a diagnose and an advice for treatment: validation and reliability Source: Eur Respir J 2004; 24: Suppl. 48, 87s Year: 2004 Supermarket baker‘s asthma: how accurate is routine health surveillance? Source: Eur Respir J 2003; 22: Suppl. 45, 490s Year: 2003 Spirometry screening in the community: is this an effective way of diagnosing early COPD? Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005